Yale University

EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library

School of Medicine

1-10-2003

Risk Factors for Delayed Diagnosis of
Subarachnoid and Intracerebral Hemorrhage
Joyce Oen-Hsiao

Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
Recommended Citation
Oen-Hsiao, Joyce, "Risk Factors for Delayed Diagnosis of Subarachnoid and Intracerebral Hemorrhage" (2003). Yale Medicine Thesis
Digital Library. 43.
http://elischolar.library.yale.edu/ymtdl/43

This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.

RISK FACTORS FOR DELAYED DIAGNOSIS OF
SUBARACHNOID AND INTRACEREBRAL
HEMORRHAGE

A Thesis Submitted to the
Yale University School of Medicine
In Partial Fulfillment of the Requirements for the
Degree of Doctor of Medicine

By
Joyce Mey Sian Oen-Hsiao
2002

ii

RISK FACTORS FOR DELAYED DIAGNOSIS OF SUBARACHNOID AND
INTRACEREBRAL HEMORRHAGE. Joyce M. Oen-Hsiao, Catherine M. Viscoli, and Walter N.
Kernan. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT.

To identify risk factors for delayed diagnosis of subarachnoid (SAH) or intracerebral (ICH)
hemorrhage in younger patients (ages 18 – 49), we performed a subsidiary case-control study
among 702 subjects from the Hemorrhagic Stroke Project (HSP). Case subjects were the 54 HSP
patients (7.7%) who did not receive an appropriate diagnostic evaluation (brain CT scan, and if CT
negative, LP) within 24 hours of consulting a physician for symptoms consistent with hemorrhagic
stroke. For each case subject with a delayed diagnosis, we identified two subjects from the HSP
with a prompt diagnosis, all successfully matched on recruitment site. We calculated odds ratios
(ORs) for the association between risk factors and delayed diagnosis.
Four features were associated with risk for delayed diagnosis (criteria: OR =2.0 or =0.5):
initial evaluation in a physician’s office (OR=23.1), absence of alarm symptoms (photophobia, loss
of consciousness, focal weakness) (OR=4.6), no effortful activity preceding focal time (OR=5.5),
and Hispanic ethnicity (OR=2.4). Risk factors associated with delayed diagnosis were different in
patients who presented to the hospital compared to patients who presented to an office. In a
separate analysis, risk factors associated with delayed diagnosis were different for patients with
SAH compared with patients with ICH.
In conclusion, patients with SAH or ICH are at greater risk for a delay in their diagnosis if
they do not have alarm symptoms, especially if they present to an office rather than a hospital
emergency department. Efforts to reduce delayed diagnosis should be directed at primary care
physicians who see low-risk patients with milder symptoms. Our findings also indicate that there
are different risk factors associated with delayed diagnosis of hemorrhagic stroke based on location
of presentation and on stroke type. Future research to understand and prevent delayed diagnosis
must consider location of presentation and stroke type.
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INTRODUCTION
I. Overview

Intracranial hemorrhage, including subarachnoid hemorrhage (SAH) and
intracerebral hemorrhage (ICH), affects approximately 102,000 persons in the United
States each year. SAH will be diagnosed in approximately 60,000 persons and ICH will
be diagnosed in 42,000 persons. (1) SAH carries a mortality rate of approximately 55% in
the first two months after initial bleed (2, 3), whereas ICH has a mortality rate between
35-52% in the first 30 days. (4-6) Of those who survive either SAH or ICH, the majority
will be left with long-term disability.
A major advance in management of patients with intracranial hemorrhage has
been the finding that early treatment improves outcome for patients with SAH. Studies
by Kassell, et al. demonstrated that poor outcome was closely associated with vasospasm
and re-bleeding and that the period of higher risk for re-bleeding was during the first
three days after the initial event.(7, 8)
Early institution of therapy after SAH is associated with reduced risk of rebleeding and improved functional outcome. (9, 10) Unfortunately, approximately 20% of
patients experience a delay in diagnosis on their initial presentation and, thus, experience
a delay in care. Although there have been many studies examining the effect of delayed
diagnosis, the frequency and reasons for delay in diagnosis are currently not well known.
While early institution of therapy of SAH has been studied, early institution of therapy
for ICH is not well documented. Although early therapy is not documented for ICH,
neurosurgeons believe in the importance of early diagnosis for ICH. (6)
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The purpose of our study, therefore, is to examine the risk factors for delayed
diagnosis of intracranial hemorrhage in both the hospital and the outpatient office
settings.

II. Epidemiology
II.1 Subarachnoid Hemorrhage

Subarachnoid hemorrhage results when a blood vessel on the surface of the brain
ruptures and bleeds into the space between the brain and the arachnoid. Usually, the
vessel ruptures at a weakened area caused by an aneurysm, or dilatation, on a blood
vessel (usually an artery). The most common type of aneurysm is a saccular protrusion
attached to the artery by a small neck.
The incidence of SAH in North America is approximately 11-12 per 100,000. (1)
Risk factors associated with risk of SAH include age, race, and gender. The incidence is
greater in older people compared with younger people. The average age of onset of SAH
is around 51 years, with most cases occurring in people over the age of 30. Although
race is not associated with a difference in the incidence for aneurysm, it has been shown
that certain populations in Japan and Finland have a higher rate of SAH from aneurysms.
(2) The frequency of aneurysmal SAH in different countries most likely reflects the
differences in population characteristics in those countries. In Cincinnati, a retrospective
cohort stud y was conducted to determine whether there was a difference in the risk of
ICH or SAH in African-Americans versus Caucasians. (11) Medical records, autopsy
reports, and CT scans of all patients who were suspected of having an ICH or SAH
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during the year were reviewed. When considering all age groups, there was a higher
incidence of both SAH and ICH in blacks when compared to whites. Blacks had 2.1
times the risk of SAH of whites. (11) The problem with this study was that subjects were
identified solely by the ICD-9-CM codes for ICH, SAH, cerebral aneurysm,
arteriovenous malformation, and cerebrovascular accident. Patients were not actively
identified on initial presentation to the hospital.
Aneurysms usually occur more frequently in men than women (4:1) up until the
fifth decade of life. The prevalence of aneurysms is equal in men and women around the
fifth decade. By the eighth decade, women have more aneurysms than men do (10:1). (2)
Gender also appears to play a role in location of aneurysms. The proximal internal
carotid is the site of more aneurysms in women, whereas the anterior communicating
region is the more prevalent site in men. (2) Demographic characteristics are not the only
factors that result in an increased risk of SAH. Clinical risk factors that lead to an
increased risk of SAH include prevalence of hypertension or atherosclerosis and diet,
tobacco, and alcohol habits.
Among all patients with a SAH, the mortality rate at one month is 45%, but most
deaths occur in the first few days. (12) The leading causes of death are acute, effects from
the initial hemorrhage, recurrent hemorrhage, and cerebral vasospasm (leading to
rebleeding or ischemic brain damage, and infarction). The volume of blood after a SAH,
calculated by CT scan, was significantly related to 30-day mortality. (12) The effects of
the initial hemorrhage are related to mortality. Patients with a worse neurological
outcome after their SAH tend to have a higher rate of mortality. The poorer the
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neurological condition of the patient and the more blood present on the initial CT scan,
the greater the likelihood of rebleeding.
Rebleeding is defined as recurrent hemorrhage due to inadequate hemostasis or
arterial vasospasm, causing a clinical decline in a patient after a SAH. In the first few
hours after SAH, up to 15% will re-bleed and up to 23 % will re-bleed within the first
two weeks. (10, 13-15) These first few ho urs appear to be the most common time for
rebleeding to occur, and early management is necessary to avoid risk of rebleeding. (12,
14) Mortality due to rebleeding has been reported to range from 50% to 80%. (10, 14)
Medical treatments to control vasospasm and early surgical interventions effectively
eliminate risk of rebleeding. (16)
Re-bleeding after a SAH event was studied by Hillman, et al. (17) Approximately
95% of patients hospitalized within 24 hours of symptom onset and 50% of patients
hospitalized within 6 hours of SAH were studied. 60% of deaths were attributed to the
initial bleeding episode, although 10% of patients admitted within 24 hours suffered from
early rebleeding. Of the rebleeding patients, 82% died and 9% had a poor outcome.
Most of the rebleeding occurred within the first 24 hours. (17) This finding is consistent
with other investigations on re-bleeding after SAH. (12, 14, 18) In all studies, the peak
incidence of rebleeding occurred within the first 24 hours after the initial hemorrhage,
with a mortality rate between 74 – 85%.
The typical patient with SAH seeks care after the sudden onset of a severe
headache often associated with loss of consciousness, focal neurological deficits, and
nuchal rigidity. The headache is usually continuous. Initially the headache is focal, but
then generalizes as time passes.
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About 8% to 10% of patients present with atypical symptoms, such as back pain,
nausea, lethargy, and eye or facial pain, and a more gradual evolution symptoms. (19, 20)
Table A lists the symptoms of 41 patients who had a delay in diagnosis of SAH after
presentation to a physician. (21) Adams et al. (21) concluded that the presence of atypical
symptoms led physicians to consider an alternate diagnosis than SAH. Other symptoms
that have been identified in patients with SAH include acute chest pain, proctalgia,
paraplegia, and leg pain. Patients can often present as confused, irritable, uncooperative,
and can sometimes exhibit combative behavior. These atypical symptoms, which were
determined to be those symptoms with a prevalence < 25%, may distract attention from
the bleed by impeding examination by the physician.
Diagnosis of SAH is made when blood is seen in the subarachnoid space either by
CT scan, angiography, lumbar puncture (LP) or at autopsy. Strategies for diagnosis of
SAH include a brain CT scan. However, in 3-4% of cases, the CT scan is normal. (22,
23) When a patient has a clinical syndrome consistent with SAH and a normal brain CT,
current guidelines recommend that physicians perform an LP to test for red blood cells
and xanthrochromasia in the CSF. (1) Xanthrochromia is a yellowish discoloration of the
CSF supernatant when the CSF is centrifuged that is a result of degradation of red blood
cells in the subarachnoid space. The disintegration of erythrocytes releases
oxyhemoglobin into the CSF, which is then converted into bilirubin. Because there exists
a risk of deterioration after LP due to herniation in patients with suspected SAH, a CT
scan and a neurological examination should be performed before the LP is done.
Poor outcome of patients affected by SAH are most closely related to three
baseline variables: 1) neurological condition of the patient on admission 2) volume and
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location of initial bleed and 3) patient’s age and compliance of the brain parenchyma.
(21-22) Of these three prognosticators, the neurological condition, particularly the level
of consciousness, is the most important determinant. (18) Prognosis of patients with SAH
can be estimated based on a clinical grading system called the Hunt and Hess Scale,
shown in Table B.
Prognosis can also be correlated to the Glasgow Coma Scale (GCS), shown in
Table C. The Glasgow Coma Scale is the most widely used scoring system used in
quantifying level of consciousness following traumatic brain injury. A lower GCS score
usually leads to higher mortality. On initial presentation after the brain injury, the best
eye opening response, the best verbal response, and the best motor response are
determined. The score (E+V+M) represents the sum of the numeric scores of each of the
categories.
The presence of other factors, such as hypertension and smoking or alcohol
history also decreases chance for survival. Location of aneurysm also affects the
prognosis, with posterior circulation aneurysms having a higher mortality rate.

II.2 Intracerebral Hemorrhage

Intracerebral Hemorrhage refers to bleeding into brain tissue, not from
subarachnoid hemorrhage. The incidence of ICH in North America is approximately 4-6
per 100,000 persons per year. (1) The incidence of ICH is low among persons below the
age of 45 years and increases dramatically from age of 65 years. After the age of 75
years of age, the incidence of ICH plateaus or decreases, due to reasons which are not
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clear, but are speculated to be due to other diseases causing mortality before ICH can
manifest itself. ICH also tends to occur more frequently in men, the difference most
likely because of presence of established risk factors for ICH. (6)
Race and ethnicity are important determinant of the risk for ICH. Asians, in
particular the Japanese, have a 2-3 times increased risk for ICH compared with other
countries. (6) In the United States, the risk of ICH is increased 2-3 fold in AfricanAmericans compared with Caucasians. (11) Under the age of 75 years, blacks had a 2.3
times greater risk of ICH than whites. This may be attributed to the increased incidence
of hypertension among African-Americans. (11) Other clinical risk factors for ICH
include diagnosis of hypertension, excessive alcohol consumption, anticoagulants, drug
use, and hypocholesterolemia.
Patients with ICH typically present with sudden onset of severe headache,
vomiting, depressed consciousness, and focal neurologic signs. Other symptoms include
seizures and nausea. There can be a progressive worsening of symptoms after the initial
abrupt headache. ICH frequently occurs during the day, with a peak in the morning just
after awakening. Hemorrhage is usually associated with activity. Symptoms associated
with ICH can vary with intensity and location of the bleed. Severe headache is reported
in only 30-40% of cases. One-third of patients with ICH do not report any headache. (6)
Although most cases of ICH ha ve been attributed to hypertension, there is an increasing
number cases in patients for whom there has not been a diagnosis of hypertension. ICH
in these patients may be associated with non-hypertensive mechanisms that include
aneurysms, tumor, vascular malformations, vasculopathies, and disorders of coagulation.
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Diagnosis of ICH is typically made when blood is seen within the brain parenchyma on
CT scan or MRI.
Prognosis after ICH is largely dependent on location of the lesion. The most
common location of ICH is within the putamen (40%). (6) The clinical spectrum of
putaminal hemorrhage ranges from small, asymptomatic lesions to large fatal lesions.
Mortality from putaminal hemorrhage ranges between 20-40%. Thalamic hemorrhage
accounts for 10-15% of ICH. Mortality rates have varied based on previous studies, but
there appears to be a direct correlation between size of the hemorrhage and mortality.
Caudate hemorrhage accounts for 5-7% of all ICH, and prognosis is generally good for
patients, with most experiencing complete recovery. Pontine hemorrhage accounts for
approximately 5% of all ICH, and when the hemorrhage involves the paramedian area
bilaterally, the hemorrhage is usually fatal. Those who survive are neurologically
devastated. Smaller pontine hemorrhages found in the basis pontis usually carry an
excellent prognosis. Cerebellar hemorrhage of the hemispheres accounts for 10% of
ICH, with a mortality rate of approximately 30%. Prognosis depends on level of clinical
function, especially level of consciousness, after the acute event.
Long-term outcome after ICH was related to the acute hemorrhage. Case- fatality
from ICH is approximately 35% to 52%. (4, 5) Mortality rates for ICH range from 20%
to 40%, although the mortality in Asian countries appears to be 2 to 3 times greater than
in Western countries. (6) Among those who survive 30 days, 50% to 70% have an
excellent recovery and are able to function independently 6 months to a year after the
acute hemorrhage. (6) Large hemorrhage size, ventricular hemorrhage, and older age are
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associated with increased risk for poor functional recovery. Recurrent hemorrhage is
rarely seen after ICH, except in hemorrhages that were not related to hypertension.
SAH and ICH are very different entities with regards to risk factors,
pathophysiology, and initial clinical presentation. Therefore, to examine hemorrhagic
stroke as one entity including both SAH and ICH may not necessarily be an effective
analysis. In order to determine whether risk factors for delayed diagnosis of hemorrhagic
stroke will be consistent for both SAH and ICH, risk factors need to be studied for each
hemorrhagic stroke type separately.

III. Importance of Early Diagnosis

Early diagnosis of both SAH and ICH is necessary to improve outcome in
survivors of the hemorrhage. By recognizing hemorrhage at its initial presentation, many
treatment options are available for the patients, from medical to surgical treatments.
Howeve r, after the first 2-3 days post-bleed, treatment options are limited, and brain
damage from inflammation or from the hemorrhage cannot be reversed. (16)

The optimal time for aneurysm surgery was studied in the International
Cooperative Study on the Timing of Aneurysm Surgery. (7, 8) A prospective,
observational clinical trial was conducted to determine the best time in relation to the
hemorrhage for surgical treatment of ruptured intracranial aneurysms. 3521 patients
hospitalized within three days of SAH were enrolled from sixty-eight centers. Patients
were grouped into prespecified "planned" surgery intervals. The day of the SAH event
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was defined as day=0. The planned surgery intervals were determined by the
neurosurgeon as soon as the diagnosis of SAH was made. Outcome rates consisted of
those patients whose surgery was planned but who were not operated on in addition to
those patients who actually had surgery. If a patient was admitted on Day 2 and had
surgery planned for between Days 7 and 10 but rebled and die on Day 6, mortality was
attributed to planned surgery of interval Days 7 to 10. If a patients was scheduled to have
surgery between Days 7 and 10 but deteriorated on Day 6, then recovered to have surgery
with a favorable outcome on Day 12, this good result would be credited to planned
surgery interval Days 7 to 10. The postoperative risk following early surgery is
equivalent to the risk of rebleeding and vasospasm in patients waiting for delayed
surgery. Analysis of these prespecified intervals demonstrated that there was no
difference in early (0 to 3 days after the bleed) or late surgery (11 to 14 days). Outcome
was worse if surgery was performed in the 7 to 10-day post-bleed interval. Surgical
results were better for patients operated on after 10 days. Overall, early surgery was
neither more hazardous nor beneficial than delayed surgery. Although 24% of patients
originally scheduled for surgery at 11-14 days and 38% of patients originally scheduled
for surgery at 15+ days, results could still be made to determine the best length of time
post-SAH that surgery should be performed. Outcomes of patients who had surgery
within three days of SAH were optimal, with 60% of the patients having a good outcome
and few neurological deficits. (7, 8)
Other studies have also shown that early diagnosis and early institution of therapy
of SAH improves functional outcome and decreases morbidity among patients with SAH.
(24-26) However, it also has been documented in multiple studies that recognition of the
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SAH is very difficult. In a study on minor leak and outcome in patients whose diagnosis
was either prompt or delayed, mortality for those patients who had a recognized minor
leak that was treated before a major rupture (0%) was much better than for those patients
whose minor leak was not identified (52%). (24)
There is a need for prompt recognition of SAH because some patients with a
ruptured aneurysm will rebleed within the first two weeks after the SAH. Despite the
evidence that early therapy improves outcome, the average interval between onset of
symptoms of intracranial hemorrhage and diagnosis is approximately 5-11 days and 18%
of patients do not seek care for > 24 hours. (27) Previous reports of SAH indicate that for
13-50% of patients, diagnosis is significantly delayed. (20-23, 27, 28) The studies on
delayed diagnosis of SAH were able to identify presenting symptoms of those patients
with a delayed diagnosis, however none were able to determine specific risk factors that
led to the delay.

IV. Delayed Diagnosis of Hemorrhagic Stroke

There are 10 prior cross-sectional studies that were done to determine outcome of
delayed diagnosis of SAH, shown in Table D. Only one (Kassell, et al., 1985) (20) also
investigated delayed diagnosis of ICH. There are five studies of delayed diagnosis that
will be discussed, in addition to a recent review of some prior studies of delayed
diagnosis of SAH.
Adams et al. (21) performed a cross-sectional study by reviewing charts of 182
patients admitted to the University of Iowa Hospital for SAH secondary to ruptured
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aneurysms. All cases of SAH were confirmed by CSF exa mination, angiography,
operation, or autopsy. Although delayed diagnosis was never defined, the assumption is
that the patients with a delayed diagnosis were those patients who received a diagnosis
different from SAH upon presentation to a physician with their symptoms. Of the 182
patients admitted, 41 (23%) had a delay ranging from one to twenty-seven days in the
diagnosis of SAH. However, upon reviewing the patient’s history and chart, Adams
noted that not all of the misdiagnosed cases were of atypical presentation or mild
symptoms. Headache was the chief complaint in 33 of the 41 patients (80%) in the
patients with delayed diagnosis. In fact, the 41 patients had a delay in diagnosis of SAH
even though headache, vomiting, and loss of consciousness were the common presenting
symptoms. The delay was attributed to local physicians making an alternate diagnosis,
although the delay by the hospital staff in the emergency department did not appear to be
included in the study.
Adams et al. (21) nicely summarizes what symptoms each patient had at the time
of initial presentation for the SAH. The alternate diagnoses were noted and reasons were
discussed as to why the alternate diagnoses were given. Infectious illness was the
diagnosis given to patients who presented with fever, malaise, nausea, vomiting, and
headache without evidence of focal neurological signs. Migraine and sinusitis were other
common diagnoses. Patients with severe neck pain and headache were diagnosed with
cervical disk he rniation or neck strain. Based on the results of the chart review, Adams et
al. concluded that a more careful search for SAH should be done in patients who present
with atypical symptoms. Also, he reiterated that prompt investigation with CT scan
and/or lumbar puncture to look for xanthrochromasia is the most useful diagnostic
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procedures to evaluate intracranial hemorrhage. This study is a concise look at the
symptoms of SAH on initial diagnosis, even recording the atypical symptoms seen.
However, the analysis of symptoms did not go beyond determining symptoms. No
analysis was done to see whether a certain symptom was a risk factor for the delayed
diagnosis of SAH.
In 1985, Kassell et al. (20) reviewed medical records for all hospitalized patients
during July 1977 and July 1983 with a discharge diagnosis of SAH at the University of
Iowa to determine the length and cause of delayed referral. Physicians referred only 36%
of the patients to the Acute Stroke Care and Monitoring Unit within 48 hours of clear cut,
recognizable signs or symptoms of SAH. The definition of the clear and recognizable
signs and symptoms of SAH was not given. Most patients were referred to the
neurosurgical stroke service several days after onset of SAH, which was detrimental to
patient care and contributed to greater morbidity and mortality.
Delays were broken down into 6 categories: physicians’ diagnostic problems,
which was defined as failure of physicians to make or suspect a diagnosis of SAH (37%);
delayed referral policy, defined as a decision by the referring physician to delay transfer
of the patient until the neurological status had improved or until an arbitrary number of
days had passed (23%); logistics, defined as delays due to scheduling or completion of
diagnostic tests (CT or angiography), initiation of treatment, or arrangements for
transportation (12%); failure of patients to seek medical attention (8%), unstable
condition (7%), or other (13%). The more common causes for delayed diagnosis were
due to physician failure to recognize the diagnosis and delays in referral policies. These
both were thought to be avoidable causes for delay. Kassell et al. (20) therefore
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concluded that public health and primary physician education was necessary to reduce the
number of patients with delayed neurosurgical care. The problem with this study is that
it only included patients who were transferred to the neurosurgical acute stroke unit from
outside the hospital. It never mentioned patients who were seen at the emergency room.
Also, only SAH was studied at this time.
Schievink et al. at the University of Amsterdam (27) conducted a cross-sectional
retrospective chart review of 334 patients admitted to the neurosurgical unit between
August 1979 and January 1987 with SAH due to aneurysmal rupture confirmed by LP,
CT, operation, angiography, or autopsy. Causes of delayed diagnosis were divided into
three categories used by Kassell et al. (20), which included patient delay, delay from
misdiagnosis, and hospital delay. Patients who presented to the hospital in bad clinical
condition were more promptly referred to the neurosurgery department compared to those
patients in good clinical condition. There was a delay in referral to the neurosurgery unit
in164 of 334 (49%) patients with SAH. Of those patients whose referral was delayed,
failure of patients to seek medical attention caused delay in 29 (18%) patients.
Physicians’ diagnostic errors were responsible for dela y in 95 (58%) patients. A delay at
the referring hospital occurred in 97 (59%) patients. The delay caused by physician
diagnostic errors averaged 10.5 days. In more than 40% of the cases, patient delay in
seeking medical attention was followed by a phys ician’s diagnostic error. This was
attributed to the less severe symptoms found in these patients.
Schievink (27) concluded that physicians were unfamiliar with SAH and that this
is the cause for the large number of incorrect diagnoses. He attributes this to the fact that
an average general practitioner would only see aneurysmal SAH once every 3 – 4 years.
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It was concluded that educating the public, medical students and physicians about the
signs and symptoms of SAH and the importance of prompt therapy to improve overall
outcome should help to decrease the number of incorrect diagnoses of SAH. Although
this study was a good evaluation of causes for delayed diagnosis in a large population,
because of the specialized neurosurgical center, the study included an overrepresentation
of posterior circulation aneurysms. Also, it was not defined whether the patients were
referred from physicians’ offices or from the emergency room.
In his study of SAH in the emergency department, Fontanarosa (23) found that 16
of 109 patients (15%) had a delayed diagnosis. These patients presented to physicians
with headache, but an otherwise normal neurologic exam. The patients did not present
with neck stiffness and the headache typically had lasted a couple of days. Of note, none
of the 16 patients who were incorrectly diagnosed had a lumbar puncture performed.
To study prevalence and outcome of patients with cerebral aneurysm who were
misdiagnosed on initial medical presentation, Mayer et al. (22) conducted a retrospective
chart review of 217 patients. Patients were studied in four tertiary-care neurosurgical
centers. Misdiagnosis was said to have occurred if the initial medical evaluation did not
consider the possibility of intracranial aneurysm or if the diagnosis of aneurysm was
delayed by more than 24 hours from the time of presentation to medical attention with
symptoms consistent with intracranial aneurysm. Of the 217 patients in the study, 54
patients (25%) with cerebral aneurysms were misdiagnosed on first presentation to a
healthcare professional for symptoms or signs of cerebral aneurysm and were initially
misdiagnosed. This misdiagnosis was associated with worse clinical outcome.
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Most of the patients who were misdiagnosed were patients in good clinical
condition whose course were more likely to deteriorate clinically. Patients were followed
based on rebleed and deterioration. Patients were clinically graded on initial presentation
using a modified Hunt and Hess grading scale. Grade was established based on best
condition achieved within the first 24 hours after initial medical presentation: Grade 1:
headache and seizure only; Grade 2: any meningeal symptoms and signs; isolated cranial
nerve palsy, nausea, or vomiting; Grade 3: altered level of consciousness; Grade 4: coma;
Grade 5: coma plus hemodynamic instability. Rates of misdiagnosis were determined for
each clinical grade. For patients with symptoms of grades 1 or 2, 46 of 121 patients
(38%) were misdiagnosed on initial presentation. For patients with altered levels of
consciousness, 6 of 56 patients (11%) were misdiagnosed on initial presentation. For
grades 4 and 5, 2 of 40 patients (5%) who were unconscious were misdiagnosed initially.
In evaluating the outcome of patients, twenty-six of 54 misdiagnosed patients
(48%) rebled or deteriorated after initial presentation to medical attention before correct
diagnosis and management was given. This was compared to only 4 out of the 163 (2%)
correctly diagnosed patients. This difference was statistically significant. In addition, for
patients with clinical grades 1 or 2, 68 of 75 (91%) of patients who were correctly
diagnosed had an excellent/good outcome compared with 24 of 45 (53%) of patients who
were initially misdiagnosed. Studying poor outcome or death in patients with clinical
grades 1 or 2, 3 of 75 (4%) of patients with correct diagnosis had poor outcome
compared with 16 of 45 (36%) of patients with misdiagnosis. Even though this study was
not designed to identify risk factors for misdiagnosis, the authors reported that most
missed cases occurred because physicians did not consider the diagnosis of SAH (and
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order a CT scan or a lumbar puncture) in the differential diagnosis of patients’
complaints.
Ferro et al. (28) looked at the causes of delayed diagnosis and referral of patients
with SAH. A prospective study was conducted of 112 patients who presented to the
departments of neurology and neurosurgery in Portugal from January 1985 to December
1987 with SAH confirmed by CT scan and/or LP or angiography. Demographic and
clinical data was recorded on admission. The causes of delayed referral were split into
categories originally used by Kassell et al.(20), including failure of the patient to seek
medical treatment, physicians’ diagnostic error, and delayed transfer policy.
This study found that the main cause of delayed referral to the neurology or
neurosurgery departments was physician inability to diagnose SAH in the 39 (70%)
patients with symptoms consistent with SAH. This study did recognize that delay due to
physician failure to consider the diagnosis does not only occur in private physician
offices. Many times, the diagnostic error can occur in the emergency room, and, in fact,
13% of the patients with delayed admission in this study were misdiagnosed in an
emergency room setting. The primary physician correctly diagnosed twenty-three
percent of the patients with a delay in admission, but there was a delay in transfer of the
patient to the hospital in time for treatment. Patients’ age or sex, presence or severity of
headache, history of hypertension, blood pressure at onset, or initial symptoms (loss of
consciousness, focal symptoms) were not factors that led to early diagnosis or referral.
Instead, early diagnosis and referral were strongly influenced by the severity of the
clinical picture. The main factor leading to physician delayed referral was mild clinical
symptoms on presentation. The severity of the initial hemorrhage also correlated with the
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length of delay in referral. The authors concluded that improving diagnostic referral is
dependent on physicians’ education rather than public education.
The remaining cross-sectional studies about delayed diagnosis of SAH were able
to identify symptoms and outcome of delayed diagnosis of SAH, with results resembling
those previously described.
Edlow et al. (29) reviewed various studies regarding misdiagnosis of
subarachnoid hemorrhage and came to three conclusions: 1) physicians consistently
misdiagnose SAH; 2) the patients with the greatest likelihood of benefiting from surgery
are the ones who most often receive an incorrect diagnosis; 3) early complications
develop in patients with an incorrect diagnosis, resulting in worse outcomes in these
patients than in those initially given a correct diagnosis. Many patients with SAH present
with findings that deviate from the classic presentation. Patients with atypical symptoms
can present with SAH during nonstrenuous activity or sleep. The headache they suffer
may present in any location. Alternatively, headache may not be present at all, with the
patient’s discomfort only evidenced by neck pain. Edlow’s review of the literature
concluded that most warning headaches are indications of unrecognized subarachnoid
hemorrhages that can be diagnosed by appropriate methods. In addition, properly
performed and interpreted CT and lumbar puncture in patients with acute, severe
headache will best identify the majority of patients with SAH.
A common conclusion of the prior studies was that physician education would
help physicians to keep hemorrhagic stroke in mind so that they will be able to promptly
identify the diagnosis and refer patients to neurosurgical centers so that early intervention
can be implemented. A study of whether an educational program for primary care
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physicians would reduce misdiagnosis or delayed diagnosis of SAH was conducted in
Sweden. (30) Both the local city population and the nine surrounding community
hospitals use the same neurosurgical center. Fridriksson et al. (30) instituted a teaching
program in the physicians’ offices in the local city population that usually refer their
neurosurgical patients to the center. Teaching focused on recognizing the most common
clinical presentation of sudden onset of headache as a sign of SAH. In addition,
maintaining individual follow- up of all referred cases opened communication between
the community physician and the neurosurgeon. No extra contact was made with the
remaining community hospitals. Outcome of patients was evaluated at 6 months after
SAH. A good outcome was defined as patients without neurological deficits (except
isolated cranial nerve palsy) returning to their premorbid activities. The educated
population had 35 cases of ruptured aneurysms with only 1 patient (3%) having a delay in
referral by the local city physician. However, in the remaining population that was not
given the teaching program, 4 of 152 (3%) patients had a delayed referral and 14 of 152
patients (9%) had a misdiagnosis of warning episodes. Therefore, the total of 18 of 152
patients (12%) had some form of delayed referral of their ruptured aneurysm.
Conclusions were that the focused attention to sudden onset headache through the
teaching program alerted local physicians to diagnose SAH at the first hemorrhagic event
in a higher percentage than average. Therefore, fewer individuals had a misdiagnosis of
their hemorrhagic stroke on transfer to the neurosurgical center. Based on these results,
one could argue that identifying the risk factors for delayed diagnosis of hemorrhagic
stroke and incorporating them into a teaching program for physicians may be beneficial
to reduce delay.

20

In summary, previous cross-sectional studies have studied the effects of delayed
diagnosis of SAH. In Iowa, Adams et al. (21) reviewed the charts of 182 patients with
SAH secondary to ruptured aneurysms and noticed that 41 patients had a delayed
diagnosis. Adams identified the symptoms of the 41 patients with a delayed diagnosis,
however he did not analyze whether the atypical symptoms were a risk for delayed
diagnosis. Kassell et al. (20) reviewed medical records for all hospitalized patients with a
SAH to determine the length and cause of delayed referral. It was determined that
physician failure to recognize the diagnosis was the most common cause for delayed
diagnosis. In Amsterdam, Schievink et al. (27) conducted a chart review of 334 patients
admitted to a neurosurgical unit with SAH and noticed that there was a delay in referral
of 164 patients. Physician’s diagnostic error was the most common cause for delay in
58% of the patients, and it was concluded that the incorrect diagnoses were most likely
the result of physicians being unfamiliar with SAH. Mayer et al. (22) conducted a chart
review of 217 patients with cerebral aneurysm to determine the prevalence and outcome
of patients with cerebral aneurysm who were misdiagnosed on initial medical
presentation. 54 of the 217 patients were cerebral aneurysms were misdiagnosed on first
presentation to a healthcare, and the delay in care of these patients was associated with a
worse outcome. Ferro et al. (28) studied the causes of delayed diagnosis and referral of
patients with SAH. Physician inability to recognize the diagnosis was the most common
cause of delayed referral in 39 of the 112 patients. In all of these studies, delayed
diagnosis was recognized to lead to worse outcome, but no analysis of symptoms
associated with delayed diagnosis was performed.
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The problem of delayed diagnosis is most commonly due to physicians failing to
consider the diagnosis of hemorrhagic stroke. There has not yet been a study adequately
designed to examine the full spectrum of risk factors for delayed diagnosis and thus
determine the features that are associated with a delayed diagnosis. Additionally, there
have been many studies with regards to delayed diagnosis of SAH, but few have
examined delayed diagnosis of ICH. Finally, there has not yet been a study to compare
delay of diagnosis in the emergency room setting versus a physicians’ office or telephone
consult.

STATEMENT OF PURPOSE AND HYPOTHESIS

The purpose of this study is to identify the risk factors associated with delayed
diagnosis of non-traumatic intracranial hemorrhage. We hypothesize that symptom
characteristics, site of care, headache history, and demographic variables may affect risk
for delayed diagnosis. The study will also identify if there is a difference between
delayed diagnosis of SAH and ICH based on the risk factors. Finally, risk factors for
delayed diagnosis will be evaluated to determine if there is a difference based on location
of initial contact. The results of this study will be useful to establish guidelines for
recognizing subarachnoid and intracerebral hemorrhage to aid physicians in early
recognition of hemorrhage, thus decreasing morbidity and mortality.
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RESEARCH METHODS

Overview
This study is designed as a subsidiary case-control study within a larger casecontrol study of the causes of hemorrhagic stroke in young persons, the Hemorrhagic
Stroke Project (HSP). (Figure 1)

Hemorrhagic Stroke Project (HSP)
HSP Selection of Cases

Between December 1994 and July 1999, case subjects with hemorrhagic stroke
were recruited from hospitals located in Connecticut, Southern Massachusetts, Southern
Ohio, Northern Kentucky, Rhode Island, and Texas. Active surveillance of all
admissions at each of the participating hospitals identified patients with hemorrhagic
stroke. Surveillance involved review of admission rosters and direct monitoring of
admissions by one or more designated individuals, such as a discharge planner or stroke
nurse. In order to check completeness of case identification, discharge rosters were
reviewed from each participating hospital during the mentioned time period.
Eligibility criteria for case subjects included admission to a participating hospital,
age between 18 and 49 years (inclusive), symptomatic primary subarachnoid hemorrhage
(SAH) or primary intracerebral hemorrhage (ICH), and ability to participate in a direct
interview within 30 days of the stroke event. Patients with other diagnoses, including
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subdural hematomas and hemorrhages associated with ischemic infarcts, trauma,
thrombolytic therapy, or cerebral vein thrombosis were not eligible for this study.
Diagnosis of SAH was based on the presence of a high intensity signa l in the
subarachnoid space by computed tomography (CT) or by lumbar puncture (LP) showing
xanthochromasia not explained by other etiologies (e.g. liver disease, increased CSF
protein, hypervitaminosis A). An ICH was diagnosed by a CT scan showing a
hyperintense signal within brain parenchyma. If other studies were not diagnostic and
after consultation with a neuroradiologist, magnetic resonance imaging (MRI) was
accepted for the diagnosis of SAH or ICH. Exclusion criteria included prior stroke and
brain lesion predisposing to hemorrhage risk (e.g. arteriovenous malformation, vascular
aneurysm, or tumor) known to exist prior to the index event. Patients were also excluded
if they first experienced stroke symptoms after being in the hospital for 72 hours for an
unrelated matter.
The treating physician gave permission to contact each potential case subject.
Once permission was received, a researcher met with the patient and reviewed pertinent
data to confirm eligibility. Eligible patients were invited to participate and give verbal
informed consent. During the consent procedure, all subjects (cases and controls) were
told that the study was designed to examine causes of hemorrhagic stroke in young
persons without specific mention of potential risk factors. Case subjects who did not
speak English were interviewed using a translator who, with rare exception, was not a
relative or acquaintance. Most interviews were conducted in the hospital, but some were
completed at home and three were complete by telepho ne.
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HSP Selection of Controls

Two matched control subjects were identified for each case subject. Matching
criteria included: gender, ethnic group (African-American versus non-AfricanAmerican), and age (within 3 years for case subjects less than 30 years and within 5 years
for cases 30 years of over). All control subject interviews had to be completed within 30
days of the case’s stroke event to minimize seasonal differences in the likelihood of
exposure to cough/cold remedies. A computer- generated list of random telephone
numbers (matching the first three digits of the case subject telephone number) was used
to identify potential control subjects. Eligibility criteria for control subjects were the
same as for case subjects except for those criteria related to the stroke event. Once an
appropriate control subject was identified, he or she was invited to participate. The
interview was then conducted in person in the control subject’s home, a doctor’s office,
or by telephone. Control subjects who traveled long distances for the interviews were
offered twenty dollars to defray the cost of their expenses.

HSP Specification of Focal Time

Each case subject was assigned a focal time. The focal time was defined as the
calendar day (i.e. index day) and time of day that marked the onset of symptoms
plausibly related to hemorrhage and that caused the case subject to seek medical
attention. To establish the focal time, a detailed account of the patient’s symptoms from
onset to diagnosis was obtained. When necessary, acquaintances or witnesses were
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consulted to determine the course of the illness. As expected, there were patients who
had symptoms compatible with a hemorrhagic stroke that predated the onset of symptoms
that caused them to seek medical attentio n. For those patients, the onset of early
symptoms was defined s the secondary (alternate) focal time. The focal time for control
subjects was defined by the day of the week and time of day that marked the case
subject’s focal time. The index day was set within 7 days of the control interview.

Delayed Diagnosis Study
Selection of Case Subjects for the Study on Delayed Diagnosis

HSP case subjects for whom diagnosis of SAH or ICH was delayed were selected
as the case subjects for the study on delayed diagnosis. These case subjects with delayed
diagnosis will be referred to as “patient” for the study on delayed diagnosis. Delayed
diagnosis was defined when HSP case subjects did not receive an appropriate diagnostic
evaluation within twenty- four hours of consulting a physician for symptoms consistent
with SAH or ICH. Consultation could have been in person or by telephone. An
appropriate diagnostic evaluation was recognized when a CT scan was obtained. An
additional requirement for SAH was that an LP must be performed if the CT scan was
negative. Among the 702 case-subjects in the HSP, patients for the delayed diagnosis
study were identified with two strategies. First, during the subject interview, all subjects
were asked, “Did you see a physician in the 2-week period before the index date?”
Second, case subjects were identified by a manual search of each subjects’ research
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record, which included discharge summaries, admit notes, and histories of the stroke
event recorded by research associates.

Selection of Controls for the Study on Delayed Diagnosis

HSP subjects who received a prompt, correct diagnosis were eligible as control
subjects in the delayed diagnosis study. Each patient was matched to a control subject
according to research site because we believed that geographical location might be
associated both with features we were studying and a delayed diagnosis. To
operationalize matching, control subjects were chosen as the next two patients enrolled in
the HSP after the case subject. To achieve greater statistical power, we selected two
controls for each case subject.

Baseline Data

All data was obtained from the HSP database except when noted with an “*”.
Data marked by “*” was obtained from the research forms, which contain a description of
the neurologic event as given by the patient. These narratives included an account of
symptoms, precipitating activities, and actions taken by the patient during the symptoms
of their stroke event. The specific data collected were grouped into demographic and
historical features, symptom features, and diagnostic features. Features are shown in the
following table:
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Features Selected for Data Collection
Demographic and

Symptom Features

Diagnostic Features

Historical Features

Age

Headache

Location of Presentation
(Hospital vs. Office vs.
Telephone) *

Gender

Photophobia

History of Migraine

Nausea/Vomiting

Headaches
Ethnicity

Loss of Consciousness *

Socio-economic Status

Focal Neurological
Symptoms

Presence of Risk Factors

Facial Pain *

(Hypertension, Cigarettes,
and Cocaine)
Family History

Neck Pain

Insurance Status

Upper Respiratory Tract
Symptoms (URI, Allergies,
Nasal Congestion)
Activity at Onset
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Selection of Features

We hypothesized that certain demographic and historical features, symptom
features, and diagnostic features of patients may have an association with delayed
diagnosis of hemorrhagic stroke. Our hypothesis was made based on the fact that
physicians make their diagnoses based on recognition of historical occurrences and
physical exam. Of the demographic features, we hypothesized that young age would be
associated with delayed diagnosis because the typical patients with SAH or ICH are
thought to be older persons with medical risk factors. We also hypothesized that
ethnicity could play a role in delayed diagnosis, with Hispanic ethnicity holding the most
association with delayed diagnosis and Black ethnicity holding the least association with
delayed diagnosis. For gender, we hypothesized that females would be more likely to
have a delayed diagnosis because of the protective effects of estrogens on the
cardiovascular system.
Of the historical features, we hypothesized that having a history of migraine
diagnosis, no history of hypertension, no history of smoking, and no primary family
history would be associated with increased risk for delayed diagnosis because a migraine
diagnosis could skew the physician’s perception of a headache. Patients without a high
risk of cardiovascular disease (hypertension, smoking, and family history) would be more
likely to have a delayed diagnosis because they are seen as “low-risk” patients. We also
hypothesized that having no college education and having no insurance would be
associated with an increased risk for delayed diagnosis secondary to bias from financial
burdens.
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Of the symptom features, we hypothesized that no photophobia, no loss of
consciousness, no focal neurological symptoms, the combination of which will be
referred to as no alarm symptoms, will have increased associatio n with delayed diagnosis
of hemorrhagic stroke. This is because mild symptoms will most likely lead a physician
to not consider a diagnosis of hemorrhage. Patients who present without facial or neck
pain or without a headache would also be likely to have a delayed diagnosis because
these symptoms are common to the presentation of hemorrhagic stroke. We also
hypothesized that nausea and vomiting symptoms would be associated with an increased
risk of delayed diagnosis because the symptoms could distract the physician into
diagnosing a gastrointestinal disorder. The presence of upper respiratory tract infection
symptoms, allergies, or nasal congestion, which will be combined into upper respiratory
tract symptoms, within the last two weeks prior to the stroke event will be associated with
an increased risk of delayed diagnosis because these symptoms can distract the physician
into attributing these symptoms to an upper respiratory tract cause. Finally, if the patient
did not have an effortful activity preceding their stroke event, we hypothesize that this
will be associated with an increased risk of delayed diagnosis.
For diagnostic features, location of initial evaluation in a physician’s office or by
telephone, which will be combined and referred to as office, will be associated with
increased risk of delayed diagnosis because of the lack of diagnostic equipment, such as a
CT scanner, in the office setting. Patients who present to a physician’s office will be
compared with patients who present to a hospital emergency room.

30

Analytic Strategy

Odds ratios were calculated for the association between pre-specified suspected
risk factors and risk for delayed diagnosis. Chi-square was used to calculate p- values.
Features were considered to be associated with delayed diagnosis of hemorrhagic stroke
if the odds ratios were greater than or equal to 2.0 or less than or equal to 0.5. To
confirm their independent association with risk for hemorrhagic stroke, features with and
odds ratio =2.0 or =0.5 were included in a multivariable logistic regression analysis.
Features were considered confirmed if their adjusted odds ratios remained =2.0 or =0.5.

RESULTS
I. Study Participants

Between December 1994 and July 1999, 702 case subjects were recruited for the
Hemorrhagic Stroke Project from hospitals located in Connecticut, Southern
Massachusetts, Southern Ohio, Northern Kentucky, Rhode Island, and Texas. Among all
case subjects, the diagnosis of intracranial hemorrhage was delayed for 54 patients
(7.7%) and prompt for 648 patients (92.3%). For each patient with a delayed diagnosis,
we identified two control subjects. Patients were matched (100%) to control subjects by
geographic location.
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II. Delayed Diagnosis Study Participants

To identify features associated with increased risk for delayed diagnosis we
compared patients with delayed and prompt diagnosis, as shown in Table E. Features are
described according to our hypotheses of how each feature may contribute to a delayed
diagnosis. The median age for patients was 40 years compared with 43 years for control
subjects. Of the patients, 34 of the 54 (63%) were ethnically Caucasian, 8 of the 54
(15%) were Black, and 8 of the 54 (15%) were Hispanic. Of the control subjects, 76 of
108 (70%) were Caucasian, 21 of the 108 (20%) were Black, and, 8 of the 108 (7%) were
Hispanic. A similar number of patients (50%) and control subjects (53%) were female.

III. Risk Factors for Delayed Diagnosis in The Overall Cohort

Table E compares patients and control subjects with respect to demographic and
historical features, symptom features, and diagnostic features. Eight features were
associated with risk for delayed dia gnosis (criteria = odds ratio=2.0 or =0.5). Compared
to patients with a prompt diagnosis, patients with a delayed diagnosis tended to be of
younger age (odds ratio=2.0, p=0.05), of Hispanic ethnicity (compared to non-Hispanic
ethnicity) (odds ratio=2.2, p=0.14), non- hypertensive (odds ratio=2.0, p=0.04), and less
educated (odds ratio=0.5, p=0.05). Compared to patients with a prompt diagnosis,
patients with a delayed diagnosis more often presented without alarm symptoms
(photophobia, loss of consciousness, and focal neurological symptoms) (odds ratio=5.3,
p=<0.01) and reported no effortful activity preceding their stroke event (odds ratio=3.0,
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p=0.08). However, compared to patients with a prompt diagnosis, patients with a delayed
diagnosis were less likely to have no headache (odds ratio=0.2, p=0.02). Finally,
compared to patients with a prompt diagnosis, patients with a delayed diagnosis more
often initially presented to a physician’s office rather than an emergency room (odds
ratio=18.3, p=<0.01).
Table F shows the results of the multivariable analysis, which includes the eight
features with a bivariate odds ratio that were statistically significant according to the
criteria of an odds ratio =2.0 or =0.5. Among the eight variables in the multivariable
analysis, there were four that remained independently associated with risk for delayed
diagnosis (criteria odds ratio =2.0 or =0.5): 1) office evaluation (adjusted odds ratio
23.1), 2) no alarm symptoms (adjusted odds ratio 4.6, with a 13% change), 3) no effortful
activity (adjusted odds ratio 5.5), and 4) Hispanic ethnicity (adjusted odds ratio 2.4).
Four variables were not longer independently associated with delayed diagnosis. For no
history of hypertension, the adjusted odds ratio was 1.5. For age <40, the adjusted odds
ratio was 1.2. For no college education, the odds ratio was 0.9. For no headache present,
the odds ratio was 0.6.

IV. Risk Factors for Delayed Diagnosis According to Type of Initial Contact

Because location of initial presentation was associated with such a large adjusted
odds ratio (23.1), we hypothesized that persons who present to an office may be
sufficiently different to warrant a stratified analysis. Accordingly, we examined the
association between location of presentation and risk feature separately for patients with
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prompt and delayed diagnoses. Our criteria for declaring that a feature was different with
regards to risk of delayed diagnosis by location of presentation was if the odds ratio was
=2.0 in one location and the odds ratio was <1.2 in the other location or if the odds ratio
was =0.5 in one location and the odds ratio was >0.8 in the other location. Additionally,
our criteria for declaring that a feature was a risk factor for delayed diagnosis in both
locations of presentation was if the odds ratio was =2.0 in both locations. Our criteria for
declaring that a feature was a protective factor for delayed diagnosis in both locations of
presentation was if the odds ratio was =0.5 in both locations. Our criteria for declaring
that a feature was associated with an increased risk for delayed diagnosis in one location
and neutral in the other was if the odds ratio was =2.0 in one location and between 1.22.0 in the other. Our criteria for declaring that a feature was considered to be protective
for delayed diagnosis in one location and neutral in the other was if the odds ratio was
=0.5 in one location and between 0.5 and 0.8 in the other. The results of the stratified
analysis are displayed in Table G.
Nine features had a different effect on risk for delayed diagnosis in the office and
hospital: young age, female gender, history of migraine diagnosis, not currently a smoker,
no college education, no alarm symptoms, nausea, upper respiratory tract symptoms, and
stroke type of ICH. For three of these nine features (young age, history of migraine
diagnosis, and no alarm symptoms) a delayed diagnosis was significantly increased when
patients presented to the hospital, but were protective or neutral when patients presented
to an office. For young age, the odds for delayed diagnosis was 2.0 among patients who
presented to the hospital compared with 0.4 among patients who presented to the office.
For history of migraine diagnosis, the odds for delayed diagnosis was 2.1 among patients
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who presented to the hospital compared with 0.4 among patients who presented to the
office. For no alarm symptoms, the odds for delayed diagnosis was 4.9 among patients
who presented to the hospital compared with 1.1 among patients who presented to the
office. For four of the nine features (female gender, not currently a smoker, upper
respiratory tract symptoms, and stroke type of ICH), a delayed diagnosis was protective
or neutral when patients presented to the hospital, but were significantly increased when
patients presented to an office. For female gender, the odds for delayed diagnosis was
0.9 among patients who presented to the hospital compared with 2.0 among patients who
presented to the office. For not currently a smoker, the odds for delayed diagnosis was
1.1 among patients who presented to the hospital compared with 3.2 among patients who
presented to the office. For upper respiratory tract symptoms, the odds for delayed
diagnosis was 0.9 among patients who presented to the hospital compared with 2.0
among patients who presented to the office. For stroke type of ICH, the odds for delayed
diagnosis was 1.1 among patients who presented to the hospital compared with 4.3
among patients who presented to the office.
For the remaining two features (no college education and nausea), a delayed
diagnosis was significantly decreased when patients presented to the office, but was
neutral when patients presented to a hospital. For no college education, the odds for
delayed diagnosis was 0.1 among patients who presented to the office compared with 1.0
among patients who presented to the hospital. For nausea, the odds for delayed diagnosis
was 0.3 among patients who presented to the office, compared to1.5 among patients who
presented to the hospital.
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Only one feature was associated with an increased risk of delayed diagnosis in
both the hospital and the office. For no effortful activity, the odds for delayed diagnosis
was 4.2 among patients who presented to the hospital compared with 2.6 among patients
who presented to the office.
One feature was associated with an increased risk for delayed diagnosis in one
location and a neutral association in the other: no hypertension history. For no
hypertension history, the odds for delayed diagnosis was 1.6 among patients who
presented to the hospital compared with 3.0 among patients who presented to the office.

V. Risk Factors for Delayed Diagnosis According to Stroke Type

Because type of stroke of ICH was associated with such a large odds ratio (4.3) in
the office location and because the pathophysiology of the diseases are substantially
different from each other, we hypothesized that persons who present with a SAH may be
different from those who present with an ICH. Accordingly, we examined the
association between type of stroke type risk feature separately for patients with prompt
and delayed diagnoses. Our criteria for declaring that a feature was different with regards
to risk of delayed diagnosis by location of presentation was if the odds ratio was =2.0 in
one location and the odds ratio was <1.2 in the other location. Additionally, our criteria
for declaring that a feature was a risk factor for delayed diagnosis in both locations of
presentation was if the odds ratio was =2.0 in both locations. Our criteria for declaring
that a feature was a protective factor for delayed diagnosis in both locations of
presentation was if the odds ratio was =0.5 in both locations. Our criteria for declaring

36

that a feature was associated with an increased risk for delayed diagnosis in one location
and neutral in the other was if the odds ratio was =2.0 in one location and between 0.52.0 in the other. Our criteria for declaring that a feature was considered to be protective
for delayed diagnosis in one location and neutral in the other was if the odds ratio was
=0.5 in one location and 0.5 to 0.8 in the other. The results of the stratified analysis are
displayed in Tables H and I.
Ten features had a different effect on risk for delayed diagnosis of SAH compared
to ICH: Caucasian ethnicity, Black ethnicity, female gender, history of migraine
diagnosis, no hypertension history, no neck pain, nausea, vomit, upper respiratory tract
symptoms, and no effortful activity. For two of these ten features (no neck pain, and no
effortful activity) a delayed diagnosis was significantly increased for patients with SAH,
but was protective or neutral for patients with ICH. Black ethnicity was a significantly
protective feature for delayed diagnosis of ICH, but was a risk for delayed diagnosis for
patients with SAH. For no neck pain, the odds for delayed diagnosis was 2.9 among
patients with SAH compared with 0.4 among patients with ICH. For no effortful activity,
the odds for delayed diagnosis was 6.9 among patients with SAH compared with 0.9
among patients with ICH. For Black ethnicity, the odds for delayed diagnosis was 1.3
among patients with SAH compared with 0.4 among patients with ICH. For five of the
ten features (Caucasian ethnicity, female gender, history of migraine diagnosis, no
hypertension history, and nausea) a delayed diagnosis was significantly increased for
patients with ICH, but was protective or neutral for patients with SAH. The remaining
two features, vomiting, and upper respiratory tract symptoms, were significantly
protective for delayed diagnosis of SAH, but were associated with risk for delayed
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diagnosis of ICH. For Caucasian ethnicity, the odds for delayed diagnosis was 2.0
among patients with ICH compared with 0.6 among patients with SAH. For female
gender, the odds for delayed diagnosis was 3.8 among patients with ICH compared with
0.3 among patients with SAH. For history of migraine diagnosis, the odds for delayed
diagnosis was 2.4 among patients with ICH compared with 0.9 among patients with SAH.
For no hypertension history, the odds for delayed diagnosis was 5.9 among patients with
ICH compared with 1.0 among patients with SAH. For nausea, the odds for delayed
diagnosis was 2.7 among patients with ICH compared with 0.6 among patients with SAH.
For vomiting, the odds for delayed diagnosis was 1.5 among patients with ICH compared
with 0.5 among patients with SAH. For upper respiratory tract symptoms, the odds for
delayed diagnosis was 1.5 among patients with ICH compared with 0.5 among patients
with SAH.
Two features were associated with an increased risk of delayed diagnosis in both
SAH and ICH: no alarm symptoms and office evaluation. For no alarm symptoms, the
odds for delayed diagnosis was 3.0 among patients who had a SAH compared with 18.5
among patients who had an ICH. For office evaluation, the odds for delayed diagnosis
was 12.4 among patients who had a SAH compared with 47.3 among patients who had an
ICH.
Three features were associated with an increased risk for delayed diagnosis in one
location and a neutral association in the other: Hispanic ethnicity, no college education,
and no headache present. For Hispanic ethnicity, the odds for delayed diagnosis was 1.9
among patients who had a SAH compared with 2.5 among patients who had an ICH. For
no college education, the odds for delayed diagnosis was 0.6 among patients who had a

38

SAH compared with 0.4 among patients who had an ICH. For no headache present, the
odds for delayed diagnosis was 0.7 among patients who had a SAH compared with 0.1
among patients who had an ICH.
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DISCUSSION

Among 702 young men and women with hemorrhagic stroke, the diagnosis was
delayed diagnosis for 54 (7.7%). Features associated with increased risk of delayed
diagnosis were Hispanic ethnicity (adjusted odds ratio=2.4), no effortful activity
preceding stroke event (adjusted odds ratio=5.5), no alarm symptoms (adjusted odds
ratio=4.6), office evaluation (adjusted odds ratio=23.1).
This is the first study to demonstrate the importance of location of presentation in
understanding the phenomenon of delayed diagnosis. Because of the magnitude of the
adjusted odds ratio for the office evaluation features, we hypothesized that persons who
present to an office may be sufficiently different from those who present to a hospital
emergency room to warrant a stratified analysis. Our results did, in fact, show that
features associated with delayed diagnosis were different based on location of initial
presentatio n. There were nine features that had a different effect on risk for delayed
diagnosis in the office and hospital: young age, female gender, history of migraine
diagnosis, not currently a smoker, no college education, no alarm symptoms, nausea,
upper respiratory tract symptoms, and stroke type of ICH.
Additionally, this is the first study to examine the association of risk features for
delayed diagnosis in both SAH and ICH. Comparison of risk features for delayed
diagnosis of SAH and ICH showed that features associated with delayed diagnosis of
SAH were different from those associated with delayed diagnosis of ICH. Ten features
had a different effect on risk for delayed diagnosis of SAH compared to ICH: Caucasian
ethnicity, Black ethnicity, female gender, history of migraine diagnosis, no hypertension
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history, no neck pain, nausea, vomit, upper respiratory tract symptoms, and no effortful
activity.
The results of the overall cohort analysis conclude that patients who present to
their physician’s office with milder clinical symptoms (no alarm symptoms) are more
likely to have a delay in diagnosis of hemorrhagic stroke. No alarm symptoms was
associated with increased risk of delayed diagnosis because when patients present with
mild symptoms, physicians usually think of less catastrophic causes. The usual
presentation for ruptured aneurysm or intracranial bleed occurs when patients are
performing activities that require some effort. Therefore, patients who present without
having done any effortful activity preceding the onset of the hemorrhagic stroke are more
likely to have a delay in diagnosis. Hispanic ethnicity may be associated with increased
risk of delayed diagnosis because of a language barrier between patient and physician.
Without an adequate interpreter, physicians may not obtain the full history of symptoms,
and therefore, may not consider the diagnosis of hemorrhagic stroke.
In evaluating the features associated with delayed and prompt diagnosis, an
important finding from our study was that most cases of delayed diagnosis of intracranial
hemorrhage occurred in patients who presented to a physician’s office. This has not been
reported in previous studies. Prior studies never made a comparison between patients
based on the location of initial presentation, and therefore, they have never demonstrated
that location of initial examination is important. The one common conclusion of prior
studies has been that physician diagnosis is the reason for delayed diagnosis. This
conclusion merely recognizes that delayed diagnosis is common, however, it does not
help to identify the features that are associated with delayed diagnosis. Our study, by
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examining the features that become risk factors for delayed diagnosis, helps physicians to
know what to look for so that SAH and ICH can be promptly diagnosed. We speculate
that this increased risk of delayed diagnosis in the office location may be due to the fact
that patients who present to an office or by telephone have milder symptoms. Our data
supports this, as is seen in Table J, where there was a higher percentage of patients who
presented to the office without alarm symptoms or facial pain. Also, more patients who
present to the office or by telephone have symptoms that were not related to any effortful
activity.
Our results also show that risk factors associated with delayed diagnosis are
different among patients who initially present to a physician in a hospital versus in an
office. No effortful activity is a feature that was associated with delayed diagnosis in
both locations of presentation. Physicians look at the symptoms and the presenting
history to determine a differential diagnosis of disease. Their differential diagnosis is
based on previous cases of the disease they have encountered. Since most patients with
SAH or ICH present with symptoms after exerting themselves, it is less likely for
physicians to think of ruptured aneurysms or vessels in patients who had no history of
exerting themselves when their symptoms began.
Features associated with delayed diagnosis in patients who present to the hospital,
but not those who present to an office setting are: young age, history of migraine
diagnosis, and no alarm symptoms. There is a tendency for delayed diagnosis of
hemorrhagic stroke in younger patients who present to the hospital because physicians do
not commonly think of hemorrhagic stroke in a younger person. Additionally, physicians
in an office may be more concerned about younger patients who present to them because
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younger patients are usually healthy and any symptoms that are persistent are not
ordinary. Therefore, physicians in an office may have a lower threshold to send younger
patients for further evaluation. A history of migraine diagnosis may result in delayed
diagnosis in the hospital, especially if the presenting symptoms are mild, because
migraine or tension headaches are the more common diagnoses seen in the emergency
room compared to hemorrhagic stroke. In the office, if a patient has a history of migraine
diagnosis, multiple headaches will lead the physician to send the patient for a work-up.
When the patient does not have any alarm symptoms, the mild symptoms in patients who
present to the hospital leads the physicians toward a milder differential diagnosis.
Physicians in the office setting may send the patient for a work- up, even though the
presenting symptoms may be mild, because they reason that if the symptoms were bad
enough for the patient to make an appointment, there must be some validity to the
symptoms.
There are three features that are associated with a delayed diagnosis in the office
or telephone setting, but are neutral in the hospital: female gender, no history of smoking,
and upper respiratory tract infection symptoms. The presence of these features made no
difference when the patient presented to a hospital. However, when patients who
presented to an office or by telephone with these features, they were more likely to have a
delayed diagnosis. This may be due to the fact that physicians in the office or by
telephone tend to downplay the complaints of women, especially if the woman has
complained before of symptoms such as headache. Physicians in an office also see
multiple cases of allergies and nasal congestion, that a person who presents with upper
respiratory tract infection symptoms is most likely to have a cold or allergies.
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There are two features that are protective for delayed diagnosis in patients who
initially present to an office or by telephone: nausea and no college education. Nausea
may lead to a more prompt diagnosis because nausea is a symptom that is commonly
associated with a neurological etiology. Therefore, patients will get worked up quicker.
Patients with a college education who presented to an office or via telephone had a
significant risk of delayed diagnosis of hemorrhagic stroke. Perhaps this is due to
physicians being reluctant to send college educated patients to the emergency room for
mild symptoms. Alternatively, educated patients may downplay their symptoms because
they reason that their symptoms are probably something insignificant. Also, physicians
may feel more comfortable to follow educated patients instead of immediately treat
because they believe that educated patients will be able to recognize worsening
symptoms and seek additional medical care if their symptoms get worse. On that line of
reasoning, less educated patients who present to their physician’s office or by telephone
would be more readily sent to the emergency room for fear that the less educated patient
will not return for medical care if they are sent away.
A feature associated with risk of delayed diagnosis in the office only is no history
of hypertension. This risk factor is also slightly increased in patients who present to the
hospital. Once again, physicians are trained to recognize constellation of symptoms and
histories. Since studies have proven that hypertension leads to vessel disease and
coronary artery disease, it is less likely for physicians to think that patients without
hypertension could have pre-disposing features that would lead to hemorrhagic stroke.
A feature associated with risk of delayed diagnosis in the hospital only is
Hispanic ethnicity. This is most likely due to a language barrier in the hospital. Hispanic
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patients who have a primary care physician usually go to a clinic with a physician who
speaks Spanish, leading to a direct interpretation of the history by the medical provider.
Our study of risk factors demonstrates the importance of distinguishing patients
who present to a hospital versus patients who present to an office or by telephone. Two
conclusions can be drawn from this portion of our study (Table G). It appears that there
are different risk factors pertaining to delayed diagnosis in the different settings of
medical care and that it may be inappropriate to combine patients who present to a
hospital for their care and patients who present to an office or call a physician via
telephone. One limitation of this portion of the study is that there were so few patients
with prompt diagnosis who presented to an office or via telephone. With such a small n,
it was hard to draw more conclusions based on office or telephone presentation. A clear
conclusion is that absence of alarm symptoms is an important factor of delayed diagnosis
in the hospital emergency room. Also, patients with a college education who present to
an office or via telephone need to have more prompt action taken for their mild
symptoms that are consistent with SAH or ICH.
Analyzing the risk factors by stroke type reveals that features of presentation of
SAH and ICH are distinct from the other. There are two features associated with a risk
for delayed diagnosis of both SAH and ICH: no alarm symptoms and office presentation.
Presentation with mild symptoms consistent with SAH or ICH will lead most physicians
to think of other diagnoses than hemorrhagic stroke. Presentation to an office with
symptoms consistent with SAH or ICH is associated with an increased risk of delayed
diagnosis. As discussed previously, the increased risk of delayed diagnosis in the office
could be because patients who go to a physician’s office present with milder symptoms
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than patients who go immediately to an emergency room for symptoms that frighten
them.
It is known that the pathophysiology of SAH and ICH are very different. The
typical presentation of each disease is distinct from the other. This became apparent in
the evaluation of risk features for delayed diagnosis based on location of presentation,
where ICH was associated with such an odds ratio of 4.3. We hypothesized that features
associated with delayed diagnosis in persons who present with a SAH may be different
from those in persons who present with an ICH. There were ten features examined that
had a different effect on risk for delayed diagnosis of SAH compared to ICH: Caucasian
ethnicity, Black ethnicity, female gender, history of migraine diagnosis, no hypertension
history, no neck pain, nausea, vomit, upper respiratory tract symptoms, and no effortful
activity.
For three of these ten features (Black ethnicity, no neck pain, and no effortful
activity) a delayed diagnosis was increased for patients with SAH, but was protective or
neutral for patients with ICH. The usual presentation of SAH is acute onset of headache
with decreased consciousness and nuchal rigidity due to a ruptured aneurysm, commonly
associated with increased intracranial pressure due to some strenuous activity. Therefore,
if a patient does not have neck pain, physicians are led to think that a headache is a
migraine or tension headache. Also, if there is no effortful activity at the onset of
symptoms, physicians may think that the symptoms are from something else besides
SAH. Black ethnicity is a protective feature for delayed diagnosis of ICH. This may be
attributed to the fact that physicians are aware that people of Black ethnicity have a
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higher risk of hypertension and coronary artery disease. Therefore, when people of Black
ethnicity present to a physician for any symptoms, they are more likely to be worked up.
For five of the ten features (Caucasian ethnicity, female gender, history of
migraine diagnosis, no hypertension history, and nausea) a delayed diagnosis was
significantly increased for patients with ICH, but was protective or neutral fo r patients
with SAH. It is unclear why Caucasian ethnicity may be associated with delayed
diagnosis of ICH. Female gender may lead to an increased risk of delayed diagnosis
because women may have migraine headaches associated with their menstrual cycle, so
headache symptoms may be attributed to other illnesses. History of migraine headaches
may be associated with increased delay in diagnosis of ICH because headaches may be
attributed to the migraine diagnosis than hemorrhage. Since the usual patients with ICH
are hypertensive, if a patient does not have a history of hypertension, the diagnosis of
ICH will fall lower on the differential. Nausea is associated with a delayed diagnosis of
ICH because nausea can be attributed to GI distress, and therefore be overlooked as a
symptom of ICH.
The remaining two features, vomiting and upper respiratory tract symptoms, were
significantly protective for delayed diagnosis of SAH, but were associated with risk for
delayed diagnosis of ICH. Vomiting is one of the signs seen with increased intracranial
pressure, which leads physicians to get a CT scan in order to rule out increased
intracranial pressure. Blood from SAH can be seen easily on CT scan. CT scan may not
pick up some ICH. Upper respiratory tract symptoms ma y also lead to diagnostic
evaluation by CT scan or MRI, which allows blood to be picked up. Again, diagnostic
studies may not pick up small ICH.
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Three features were associated with an increased or decreased risk for delayed
diagnosis of ICH and a neutral effect on SAH: Hispanic ethnicity, no college education,
and no headache present. Hispanic ethnicity tends to be a risk for delayed diagnosis of
ICH, but has a neutral (albeit barely neutral) effect on SAH. This may be due to severity
of symptoms from ICH versus SAH. If the patient presents with small hemorrhages in
the basal ganglia due to ICH, it may be difficult for the physician to locate a focal
neurological deficit, whereas if an aneurysm ruptures, as in SAH, focal deficits are
usually more obvious. Therefore, less interpretation is required when evaluating a patient
with ruptured SAH, possibly accounting for the difference in Hispanic ethnicity.
Features that are protective for delayed diagnosis of ICH are no college education and no
headache. Reasons for delay if a patient is more educated have been discussed
previously. However, no headache as a protective feature may be because of location of
the ICH. Some patients with ICH present without any headache, but with other
neurological deficits. These patients are more likely to be worked up, thereby leading the
results to consider no headache as a protective feature.
The results of our study are strikingly different from previous studies on delayed
diagnosis of SAH. Only 54 of 702 (7.7%) patients had a delayed diagnosis of
hemorrhagic stroke. This estimate compares to 15% to 64% in other published research.
(20)(18) The reason that our estimate may be lower than other studies include: 1) we only
enrolled patients who survived their hemorrhagic stroke 2) younger patients are more
likely to seek medical care, and 3) the rigorous case definition that was strictly adhered to
minimized misclassification. In terms of patient selection, our cohort excluded people
who had died from their neurological event. However, based on our data thus far, most
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of the patients who have a delayed diagnosis are more likely to have worse outcome.
Therefore, excluding those who had died would only support our results that delayed
diagnosis leads to increase morbidity and mortality. In terms of methodology, bias was
minimized during data collection by including participants not only presenting at the
hospital, but also presenting initially to a physician in an office or by telephone.
Additionally, trained individuals who used active surveillance to identify patients
collected data from hospitals in four geographical regions. There was no doubt of
diagnosis in our study because of the strict definition of delayed diagnosis that was
adhered to throughout the study requiring that a diagnosis of SAH or ICH be proven with
a CT scan or by LP. To minimize recall bias, patients were asked the same questions
regarding their event from an interview booklet. Additionally, medical records were
read, and patients and family members were interviewed in detail to classify the patient
according to pre-specified criteria for delay. We are confident that this study is a true
estimate of risk factors for delayed diagnosis of SAH and ICH.

Conclusion

In summary, our study has shown that features associated with increased risk of
delayed diagnosis were Hispanic ethnicity, no effortful activity preceding stroke event,
no alarm symptoms, and office evaluation. When we further stratified the analysis based
on location of presentation, our study showed that the features associated with delayed
diagnosis of hemorrhagic stroke were different in patients who presented to an office
compared with an emergency room. Finally, stratification by stroke type determined that
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SAH and ICH must be studied separately, as risk factors for delayed diagnosis of SAH
differed from those of ICH.
The results of our study will be helpful to recognize those patients with
hemorrhagic stroke who do not present with the classic symptoms for SAH or ICH. By
recognizing the features that are associated with delayed diagnosis of hemorrhagic stroke,
prompt diagnosis can be made and early patient referral for treatment can be
implemented. Early patient referral will help to decrease risk of vasospasm and re-bleed
in the 3-4 days following the initial event, and thus decrease the morbidity and mortality
rates of patients with intracranial hemorrhage. (16, 20, 22)
Stratifying the risk features showed that there are different risk factors for delayed
diagnosis based on location that patients present to with their initial symptoms of
hemorrhagic stroke. An important conclusion is that patients were more likely to have a
delayed diagnosis if they went to see a physician in an office. Results for associated risk
factors based on location of presentation were consistent with the initial analysis of
features leading to increased risk of delayed diagnosis. Young patients who presented to
the office without any alarm symptoms were more likely to have a delayed diagnosis.
The results of this case-control study have also shed some light on the risk factors that
can lead to delayed diagnosis of ICH. Risk factors for delayed diagnosis of SAH and
ICH are very different, which supports the fact that clinical features of SAH and ICH
should be studied as separate diseases rather than be combined as hemorrhagic stroke.
Our study has shown that there are many features of patients who present with ICH
which need to be considered in patients who come with symptoms suggestive of ICH. In
particular, physicians who see young women with no history of hypertension in their
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office or who speak with them via telephone need to consider the diagnosis of ICH more
strongly. In addition, further history and evaluation need to be obtained in patients who
present with headache in order to be sure that a diagnosis of ICH is not missed.
There have been many studies investigating delayed diagnosis in subarachnoid
hemorrhage, but only one study that included delayed diagnosis in intracerebral
hemorrhage. (22) These studies have been able to determine the outcome of the patients
after the delay, but none have been able to determine factors that can lead to delayed
diagnosis. In addition, the studies performed were cross-sectional studies, which could
not statistically conclude that certain risk factors were present for the delay in diagnosis.
The results of our case-control study will aid physicians to be able to recognize
presentations of SAH and ICH in order to promptly diagnose the hemorrhagic stroke and
refer the patient for treatment as quickly as possible to reduce morbidity and mortality.
The need to study ICH and SAH as separate entities is not a new idea, however, never
before was the data regarding risk factors of presenting symptoms statistically analyzed.
Our results show clearly that SAH and ICH must be looked at separately when studying
risk factors that may lead to delayed diagnosis of each stroke type. Our results also show
that there is a difference in the risk factors associated with delayed diagnosis in the office
setting compared with the hospital. To further understand the phenomenon of delayed
diagnosis and identify strategies to prevent it, it will be important to account for the
important delay occurring in the office and to recognize that the risk factors for delayed
diagnosis may be different according to where a patient initially presents.
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Implications

Implications of our study show that efforts are needed to reduce delay in
diagnosis among primary care physicians and hospital physicians who see low-risk
patients who may present with mild initial symptoms. Features associated with delayed
diagnosis of SAH were vastly different from those associated with delayed diagnosis of
ICH, proving that it is not sufficient to study hemorrhagic stroke as one entity. Each
specific stroke type needs to be studied on its own to determine more specific features
associated with delayed diagnosis of each individual stroke type.
Additionally, it appears that features associated with delayed diagnosis are
different based on location of initial presentation of symptoms. We recognize that
evaluation of SAH and ICH based on location of initial medical contact was limited in
this study because of small numbers. However, the results that were obtained show that
it would be worthwhile for future studies examining delayed diagnosis to separately
evaluate the risk factors of those patients who initially present to a physician’s office
from the patients who initially are seen in the emergency room.
Additional studies are necessary to further understand delayed diagnosis of
hemorrhagic stroke and to evaluate risk factors for delayed diagnosis in the hospital
separate from the risk factors for delayed diagnosis in the physician’ s office. By
recognizing that most delayed diagnoses occur in an office, future studies will be able to
determine the specific symptoms that physicians need to be aware of in each location of
evaluation in order to reduce the incidence of delayed diagnosis of hemorrhagic stroke.
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Figure 1. Diagram of Cohort Assembly
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Table A:
Presenting Symptoms of Subarachnoid Hemorrhage in 41 Patients with
Delayed Diagnosis
(Adams, et al., JAMA 244:794-796, 1980)
Symptom

No. of Patients (%)

Headache

35 (85)

Nausea

18 (44)

Vomiting

14 (34)

Brief Loss of Consciousness

13 (32)

Neck Stiffness or Pain

6 (15)

Hemiparesis

6 (15)

Vertigo

6 (15)

Faintness

5 (12)

Confusion

3 (7)

Convulsions

3 (7)

Coma

3 (7)

Hearing Loss

3 (7)

Visual Loss

2 (5)

Diploplia

2 (5)

Malaise and Diffuse Aches

2 (5)

Photophobia

1 (2)

Back Pain

1 (2)
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Table A (continued):
Presenting Symptoms of Subarachnoid Hemorrhage in 41 Patients with
Delayed Diagnosis
(Adams, et al., JAMA 244:794-796, 1980)
Leg Pain

1 (2)

Ataxia

1 (2)

Speech Disturbance

1 (2)

Chest Pain

1 (2)

Paraparesis

1 (2)
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Table B: The Hunt and Hess Scale for Grading of Subarachnoid Hemorrhage
Grade

Motor Deficit

0

Intact aneurysm.

1

Asymptomatic.
Mild headache and slight nuchal rigidity.

1a

No acute meningeal/brain reaction but with fixed neurological deficit.

2

Cranial nerve palsy.
Moderate to severe headache.
Nuchal rigidity.

3

Mild focal deficit.
Lethargy or confusion.

4

Stupor.
Moderate to severe hemiparesis.
Early decerebrate rigidity.

5

Deep coma.
Decerebrate rigidity.
Moribund appearance.
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Table C: The Glasgow Coma Scale*
Glasgow Coma Scale

Eye Opening (E)

Verbal Response (V)

Motor Response (M)

4=Spontaneous

5=Normal conversation

6= Obeys commands fully

3=To voice

4=Disoriented conversation

5=Localizes to noxious stimuli

2=To pain

3=Words, but not coherent

4=Withdraws from noxious stimuli

1=No Eye Opening

2=Incomprehensible sounds

3= Abnormal flexion, i.e.

1=No Sounds

decorticate posturing
2= Extensor response, i.e.
decerebrate posturing
1= No response

* Glasgow Coma Score is calculated as E+V+M

Table D: Summary of Previous Studies on Delayed Diagnosis of Intracranial Hemorrhage
Study (Year)

Study Type

Method of Patient

Source of Data

Selection

Stroke Type

Number

Delayed

Studied

of

Diagnosis

Patients

n (%)

Adams et al. (1980)

Cross-Sectional

Discharge Diagnosis

Medical Records

SAH

182

41 (23)

Jain et al. (1983)

Cross-Sectional

Discharge Diagnosis

Medical Records

SAH

90

31 (34)

Kassell et al. (1985)

Cross-Sectional

Discharge Diagnosis

Medical Records,

SAH

150

56 (37)*

patients, family

96 (64)

members, physicians
Schievink et al. (1988)

Cross-Sectional

Discharge Diagnosis

Medical Records

SAH

334

52 (16)*
164 (49)

Fontanarosa (1989)

Cross-Sectional

Discharge Diagnosis

Medical Records

* This percentage reflects delayed diagnosis due only to physician diagnostic error.

SAH

109

16 (15)

Table D: Summary of Previous Studies on Delayed Diagnosis of Intracranial Hemorrhage
Study (Year)

Study Type

Method of Patient

Source of Data

Selection

Ferro et al. (1991)

Cross-Sectional

Triage Surveillance

Data Collected at Time

Stroke Type

Number

Delayed

Studied

of

Diagnosis

Patients

n (%)

SAH

112

56 (50)

15 (16)

of Admission; followed
until referral to
neurosurgical unit
Chan et al. (1991)

Cross-Sectional

Discharge Diagnosis

Medical Records

SAH

94

Sved et al. (1995)

Cross-Sectional

Discharge Diagnosis

Medical Records

SAH

511

Mayer et al. (1996)

Cross-Sectional

Discharge Diagnosis

Medical Records

SAH and ICH

217

54 (25)

Neil-Dwyer et al.

Cross-Sectional

Discharge Diagnosis

History and Data

SAH

136

69 (51)

(1997)

Collected at Time of
Admission

* This percentage reflects delayed diagnosis due only to physician diagnostic error.
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Table E: Baseline Features among patients with delayed and prompt diagnosis of
hemorrhagic stroke*
Demographic and Historical

Delayed

Prompt

Features

Diagnosis

Diagnosis

N=54
n (%)

N=108
n (%)

40

43

24 (44)

Caucasian

Odds Ratio

P-value

31 (29)

2.0

0.05

43 (80)

85 (79)

1.1

0.89

Black

8 (15)

21 (19)

0.7

047

Hispanic

8 (15)

8 (7)

2.2

0.14

Gender: Female

27 (50)

57 (53)

0.9

0.74

History of Migraine Headaches

10 (19)†

15 (14)†

1.5

0.40

No History of Hypertension

38 (70)

58 (54)

2.0

0.04

Not Currently a Smoker

25 (46)

54 (50)

0.9

066

No Family History

51 (94)

101 (94)

1.5

0.62

No College Education

27 (50)

71 (66)

0.5

0.05

No Insurance

9 (17)†

15 (14)†

1.3

0.62

Age, years (median)
Age < 40
Race/Ethnicity

* features are described in table according to hypothesis of how each feature would
contribute to delayed diagnosis
†
indicates that there are 1-3 subjects missing from the stated n
‡
indicates that there are 4-6 subjects missing from the stated n
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Table E: Baseline Features among patients with delayed and prompt diagnosis of
hemorrhagic stroke*
Delayed

Prompt

Diagnosis

Diagnosis

N=54
n (%)

N=108
n (%)

No Alarm Symptoms

34 (63)

No Photophobia

Symptom Features

Odds Ratio

P-value

26 (24)†

5.3

<0.01

45 (83)

79 (74)†

1.8

0.18

No Loss of Consciousness

50 (93)

85 (81)†

2.9

0.05

No Focal Neurological Sx

45 (83)

63 (58)

3.6

<0.01

No Facial Pain

53 (98)

105 (97)

1.5

0.72

No Neck Pain

35 (65)

57 (53)

1.6

0.14

2 (4)†

18 (17)†

0.2

0.02

Nausea

27 (52)†

52 (50)‡

0.9

0.87

Vomiting

25 (48)†

57 (56)‡

1.4

0.36

Upper Respiratory Tract Sx

19 (39)‡

47 (46)‡

0.7

0.40

URI Symptoms

8 (16)‡

19 (18)‡

0.9

0.77

Allergies

9 (18)‡

25 (24)‡

0.7

0.43

Nasal Congestion

15 (29)

30 (29)‡

1.0

1.00

No Effortful Activity

50 (94)†

90 (85)†

3.0

0.08

No Headache Present

* features are described in table according to hypothesis of how each feature would
contribute to delayed diagnosis
†
indicates that there are 1-3 subjects missing from the stated n
‡
indicates that there are 4-6 subjects missing from the stated n
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Table E: Baseline Features among patients with delayed and prompt diagnosis of
hemorrhagic stroke*

Diagnostic Features

Location of Evaluation:

Delayed

Prompt

Diagnosis

Diagnosis

N=54
n (%)

N=108
n (%)

28 (52)

24 (44)

Odds Ratio

P-value

6 (6)

18.3

<0.01

41 (38)

1.3

0.43

Office or Telephone
Stroke Type: ICH

* features are described in table according to hypothesis of how each feature would
contribute to delayed diagnosis
†
indicates that there are 1-3 subjects missing from the stated n
‡
indicates that there are 4-6 subjects missing from the stated n
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Table F: Results of a Multivariable Analysis for clinical features associated with
increased risk for delayed diagnosis

Feature*

Adjusted OR

P-value

Office or Telephone Evaluation

23.1

<0.0001

No Alarm Symptoms

4.6

0.0013

No Effortful Activity

5.5

0.08

Hispanic Ethnicity

2.4

0.19

No History of Hypertension

1.5

0.41

Age < 40

1.2

0.68

No College Education

0.9

0.92

No Headache Present

0.6

0.51

* Features were included in the model if the odds ratio in a bivariate analysis was > 2.0 or
<0.5 (see Table E)

68

Table G: Features Associated with Delayed Diagnosis According to Type of Initial Contact

Presented to Hospital
Demographic and

Delayed

Prompt

Historical Features

Presented to Office/by Telephone

Odds

P-

Ratio

value

N = 26
n (%)

N = 102
n (%)

11 (42)

27 (26)

2.0

Caucasian

20 (77)

79 (77)

Black

6 (23)

Hispanic

Delayed Prompt

Odds

P-

Ratio

value

N = 28
n (%)

N=6
n (%)

0.11

13 (46)

4 (67)

0.4

0.37

1.0

0.95

23 (82)

6 (100)

–

0.26

21 (21)

1.2

0.78

2 (7)

0 (0)

–

0.50

6 (23)

8 (8)

3.5

0.03

2 (7)

0 (0)

–

0.50

Female

13 (50)

55 (54)

0.9

0.72

14 (50)

2 (33)

2.0

0.46

History of Migraine Dx

6 (24) †

13 (13) †

2.1

0.16

4 (15) †

2 (33)

0.4

0.29

No Hypertension History

17 (65)

55 (54)

1.6

0.29

21 (75)

3 (50)

3.0

0.22

Not Currently a Smoker

14 (54)

53 (52)

1.1

0.86

11 (39)

1 (17)

3.2

0.29

25 (100) †

95 (94) †

–

0.21

26 (93)

6 (100)

–

0.50

No College Education

17 (65)

66 (65)

1.0

0.95

10(36)

5 (83)

0.1

0.03

Not Insured

5 (20) †

15 (15) †

1.4

0.53

4 (14)

0 (0)

–

0.32

Age < 40 Years
Race

No Primary Family History

* indicates that these symptoms were present the 2 weeks before initial presentation to physician
for symptoms consistent with hemorrhagic stroke
†
indicates that there are 1-3 subjects missing from the stated n
‡
indicates that there are 4-6 subjects missing from the stated n
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Table G: Features Associated with Delayed Diagnosis According to Type of Initial Contact
Presented to Hospital
Symptom Features

Delayed

Prompt

Presented to Office/by Telephone

Odds

P-

Ratio

value

N = 26
n (%)

N = 102
n (%)

No Alarm Symptoms

15 (58)

22 (22) †

4.9

No Photophobia

21 (81)

75 (74) †

No Loss of

23 (88)

Delayed Prompt

Odds

P-

Ratio

value

N = 28
n (%)

N=6
n (%)

0.0003

19 (68)

4 (67)

1.1

0.95

1.5

0.49

24 (86)

4 (67)

3.0

0.27

79 (80) †

1.9

0.31

27 (96)

6 (100)

–

0.64

22 (85)

57 (56)

4.3

0.007

23 (82)

6 (100)

–

0.26

No Facial Pain

25 (96)

99 (97)

0.8

0.81

28 (100)

6 (100)

–

No Neck Pain

17 (65)

57 (56)

1.5

0.38

18 (64)

0 (0)

–

0.004

No Headache Present

1 (4) †

18 (18)

0.2

0.09

1 (4) †

0 (0) †

–

0.70

Nausea

15 (60) †

49 (49) †

1.5

0.35

12 (44) †

3 (75) †

0.3

0.25

Vomiting

15 (60) †

53 (54) ‡

1.3

0.60

10 (37) †

4 (100) †

–

0.02

Upper Respiratory Tract Sx

11 (44)

46 (47)

0.9

0.76

8 (33) ‡

1 (20) †

2.0

0.56

URI Symptoms*

4 (17) †

19 (19) †

0.9

0.84

4 (15) †

0 (0) †

–

0.35

Allergies*

5 (22) †

24 (24) †

0.9

0.80

4 (15) †

1 (20) †

0.7

0.80

Nasal Congestion*

9 (35)

29 (30) ‡

1.2

0.67

6 (24) †

1 (17)

1.6

0.70

24 (96) †

85 (85) †

4.2

0.14

26 (93)

5 (83)

2.6

0.46

Consciousness
No Focal Weakness

No Effortful Activity

* indicates that these symptoms were present the 2 weeks before initial presentation to physician
for symptoms consistent with hemorrhagic stroke
†
indicates that there are 1-3 subjects missing from the stated n
‡
indicates that there are 4-6 subjects missing from the stated n
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Table G: Features Associated with Delayed Diagnosis According to Type of Initial Contact
Presented to Hospital
Diagnostic Features

Stroke Type: ICH

Delayed

Prompt

N = 26
n (%)

N = 102
n (%)

11 (42)

40 (39)

Presented to Office/by Telephone

Odds

P-

Ratio

value

1.1

0.77

Delayed Prompt

N = 28
n (%)

N=6
n (%)

13 (46)

1 (17)

Odds

P-

Ratio

value

4.3

0.18

* indicates that these symptoms were present the 2 weeks before initial presentation to physician
for symptoms consistent with hemorrhagic stroke
†
indicates that there are 1-3 subjects missing from the stated n
‡
indicates that there are 4-6 subjects missing from the stated n
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Table H: Features Associated with Delayed Diagnosis of Subarachnoid Hemorrhage

SAH
Demographic and Historical

Delayed

Prompt

Odds Ratio

P-value

N = 30
n (%)

N = 67
n (%)

12 (40)

23 (34)

1.3

0.59

Caucasian

24 (80)

58 (87)

0.6

0.41

Black

5 (17)

9 (13)

1.3

0.68

Hispanic

4 (13)

5 (7)

1.9

0.36

Female

10 (33)

41 (61)

0.3

0.01

History of Migraine Diagnosis

4 (14)†

10 (15)†

0.9

0.91

No Hypertension History

19 (63)

42 (63)

1.0

0.95

Not Currently a Smoker

13 (43)

28 (42)

1.1

0.89

No Primary Family History

30 (100)

63 (94)

–

0.17

No College Education

16 (53)

43 (64)

0.6

0.31

Not Insured

5 (17)

11 (16)

1.0

0.98

Features

Age < 40 Years
Race

†
‡

indicates that there are 1-3 subjects missing from the stated n
indicates that there are 4-6 subjects missing from the stated n
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Table H: Features Associated with Delayed Diagnosis of Subarachnoid Hemorrhage
SAH
Symptom Features

Delayed

Prompt

Odds Ratio

P-value

N = 30
n (%)

N = 67
n (%)

No Alarm Symptoms

18 (60)

22 (33)†

3.0

0.01

No Photophobia

25 (83)

43 (64)

2.8

0.06

No Loss of Consciousness

26 (87)

53 (82)†

1.5

0.53

No Focal Neurological Sx

25 (83)

55 (82)

1.1

0.88

No Facial Pain

29 (97)

65 (97)

0.9

0.93

No Neck Pain

17 (57)

21 (31)

2.9

0.02

1 (3)†

3 (5)†

0.7

0.80

Nausea

16 (55)†

42 (66)†

0.6

0.34

Vomiting

15 (52)†

44 (70)‡

0.5

0.09

Upper Respiratory Tract Sx

9 (33)†

34 (52)†

0.5

0.11

URI Symptoms (in 2 weeks)

2 (7)†

15 (23)†

0.3

0.07

Allergies (in 2 weeks)

6 (21)†

16 (25)†

0.8

0.74

Nasal Congestion (in 2 weeks)

8 (30)†

21 (32)†

0.9

0.80

28 (97)†

53 (80)†

6.9

0.04

No Headache Present

No Effortful Activity
†
‡

indicates that there are 1-3 subjects missing from the stated n
indicates that there are 4-6 subjects missing from the stated n
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Table H: Features Associated with Delayed Diagnosis of Subarachnoid Hemorrhage
SAH
Diagnostic Features

Location of Evaluation:

Delayed

Prompt

N = 30
n (%)

N = 67
n (%)

15 (50)

5 (7)

Office or Telephone
†
‡

indicates that there are 1-3 subjects missing from the stated n
indicates that there are 4-6 subjects missing from the stated n

Odds Ratio

P-value

12.4

<.0001
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Table I: Features Associated with Delayed Diagnosis of Intracerebral Hemorrhage

ICH
Demographic and Historical

Delayed

Prompt

Odds Ratio

P-value

N = 24
n (%)

N = 41
n (%)

12 (50)

8 (20)

4.1

0.01

Caucasian

19 (79)

27 (66)

2.0

0.25

Black

3 (13)

12 (29)

0.3

0.12

Hispanic

4 (17)

3 (7)

2.5

0.24

Female

17 (71)

16 (39)

3.8

0.01

History of Migraine Diagnosis

6 (25)

5 (12)

2.4

0.18

No Hypertension History

19 (79)

16 (39)

5.9

0.002

Not Currently a Smoker

12 (50)

26 (63)

0.6

0.29

No Primary Family History

21 (88)

38 (93)

0.6

0.56

No College Education

11 (46)

28 (68)

0.4

0.07

Not Insured

4 (17)†

4 (10)†

1.9

0.40

Features

Age < 40 Years
Race

†
‡

indicates that there are 1-3 subjects missing from the stated n
indicates that there are 4-6 subjects missing from the stated n
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Table I: Features Associated with Delayed Diagnosis of Intracerebral Hemorrhage
ICH
Symptom Features

Delayed

Prompt

Odds Ratio

P-value

N = 24
n (%)

N = 41
n (%)

No Alarm Symptoms

16 (67)

4 (10)

18.5

<.0001

No Photophobia

20 (83)

36 (90)†

0.6

0.44

No Loss of Consciousness

24 (100)

32 (80)†

No Focal Weakness

20 (83)

8 (20)

20.6

<.0001

No Facial Pain

24 (100)

40 (98)

–

0.44

No Neck Pain

18 (75)

36 (88)

0.4

0.18

1 (4)†

15 (37)

0.1

0.004

Nausea

11 (48)†

10 (26)†

2.7

0.07

Vomiting

10 (43)†

13 (33)†

1.5

0.42

Upper Respiratory Tract Sxs

10 (45)†

13 (36)‡

1.5

0.48

URI Symptoms (in 2 weeks)

6 (29)†

4 (10)†

3.5

0.07

Allergies (in 2 weeks)

3 (14)†

9 (23)†

0.6

0.42

Nasal Congestion (in 2 wks)

7 (29)

9 (24)‡

1.3

0.67

22 (92)

37 (93)†

0.9

0.90

No Headache Present

No Effortful Activity
†
‡

indicates that there are 1-3 subjects missing from the stated n
indicates that there are 4-6 subjects missing from the stated n

0.02
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Table I: Features Associated with Delayed Diagnosis of Intracerebral Hemorrhage
ICH
Diagnostic Features

Location of Evaluation:

Delayed

Prompt

N = 24
n (%)

N = 41
n (%)

13 (54)

1 (2)

Office or Telephone
†
‡

indicates that there are 1-3 subjects missing from the stated n
indicates that there are 4-6 subjects missing from the stated n

Odds Ratio

P-value

47.3

<.0001
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Table J: Comparison of Percentage of Patients and Control Subjects According to
Type of Initial Contact

Demographic and

Presented to Hospital

Presented to Office
or by Telephone

N = 128
n (%)

N = 34
n (%)

38 (30)

17 (50)

Caucasian

99 (77)

29 (85)

Black

27 (21)

2 (6)

Hispanic

14 (11)

2 (6)

Female

68 (53)

16 (47)

History of Migraine Dx

19 (15)

6 (18)

No Hypertension History

72 (56)

24 (71)

Not Currently a Smoker

67 (52)

12 (35)

No Primary Family History

120 (95)

32 (94)

No College Education

83 (65)

15 (44)

Not Insured

20 (16)

4 (12)

Historical Features

Age < 40 Years
Race
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Table J: Comparison of Percentage of Patients and Control Subjects According to
Type of Initial Contact
Symptom Features

Presented to Hospital

Presented to Office
or by Telephone

N = 128
n (%)

N = 34
n (%)

No Alarm Symptoms

37 (29)

23 (68)

No Photophobia

96 (76)

28 (82)

No Loss of

102 (82)

33 (97)

79 (62)

29 (85)

No Facial Pain

124 (97)

34 (100)

No Neck Pain

74 (58)

18 (53)

No Headache Present

19 (15)

1 (3)

Nausea

64 (52)

15 (48)

Vomiting

68 (55)

14 (46)

Upper Respiratory Tract Sx

57 (47)

9 (31)

URI Symptoms*

23 (19)

4 (13)

Allergies*

29 (24)

5 (16)

Nasal Congestion*

38 (31)

7 (23)

No Effortful Activity

109 (87)

31 (91)

Consciousness
No Focal Weakness
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Table J: Comparison of Percentage of Patients and Control Subjects According to
Type of Initial Contact

Diagnostic Features

Stroke Type: ICH

Presented to Hospital

Presented to Office
or by Telephone

N = 128
n(%)

N = 34
n (%)

51 (40)

14 (41)

